As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
Mar '25 |
+/-
%
|
||
Revenue | 1.74 1.74 |
10%
10%
|
|
Gross Profit | 0.37 0.37 |
33%
33%
|
|
EBITDA | -2.60 -2.60 |
13%
13%
|
EBIT (Operating Income) EBIT | -2.68 -2.68 |
7%
7%
|
Net Profit | -3.30 -3.30 |
6%
6%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Its product categories includes directly-oral, after-soaking-oral, fine, and regular TCMP. It distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.
Head office | Virgin Islands, British |
CEO | Sze Zhou |
Employees | 75 |
Founded | 2005 |
Website | www.sxtchina.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.